Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Inflammation01:38

Inflammation

Overview
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Working towards full eradication of lipid-driven cardiovascular risk?

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
Same author

The challenge of choosing in cardiovascular risk management.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
Same author

From evidence to practice: development of web-based Dutch lipid reference values.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
Same author

[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]

Nederlands tijdschrift voor geneeskunde·2020
Same author

Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia.

Expert review of cardiovascular therapy·2020
Same author

Efficacy of Concentrated n-3 Fatty Acids in Hypertriglyceridaemia : A Comparison with Gemfibrozil.

Clinical drug investigation·2016

Related Experiment Video

Updated: Jul 13, 2026

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Systemic inflammation as a risk factor for atherothrombosis.

S I van Leuven1, R Franssen, J J Kastelein

  • 1Academic Medical Center, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. s.i.vanleuven@amc.uva.nl

Rheumatology (Oxford, England)
|August 19, 2007
PubMed
Summary

Chronic inflammatory diseases like SLE and RA, and infections like HIV, increase cardiovascular disease (CVD) risk. Early cardiovascular protection is crucial due to inflammation promoting atherosclerosis years before diagnosis.

Related Experiment Videos

Last Updated: Jul 13, 2026

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Area of Science:

  • Immunology
  • Cardiology
  • Infectious Diseases

Background:

  • Chronic inflammatory disorders, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), are linked to higher cardiovascular disease (CVD) rates.
  • Chronic infections with an inflammatory component, such as human immunodeficiency virus (HIV), also elevate CVD risk.
  • Cardiovascular mortality is a significant cause of death in patients with these conditions.

Purpose of the Study:

  • To highlight the link between systemic inflammation and cardiovascular disease.
  • To emphasize the early onset of atherothrombotic processes in chronic inflammatory states.
  • To advocate for early cardiovascular protection strategies in at-risk patient populations.

Main Methods:

  • Review of existing literature on chronic inflammation and cardiovascular disease.
  • Analysis of pathophysiological mechanisms linking inflammation to atherogenesis.
  • Examination of the pre-clinical phase of cardiovascular disease development.

Main Results:

  • Systemic inflammation directly and indirectly promotes atherothrombotic vascular disease.
  • Atherogenesis can begin years before the clinical diagnosis of chronic inflammatory diseases.
  • Widespread risk factor exposure occurs during the pre-clinical phase.

Conclusions:

  • Patients with chronic inflammatory disorders and infections face elevated CVD risk.
  • Early intervention is necessary to mitigate cardiovascular risks associated with systemic inflammation.
  • Proactive cardiovascular protection strategies are warranted in individuals predisposed to inflammation-driven vascular disease.